252 related articles for article (PubMed ID: 17490542)
1. Correlation of class II transactivator with HLA-DR antigen and its implications.
Xu KL; Li H; Pan XY; Li ZY; Lu QX; Zhang Y; Zhu HH; DU B; Zeng LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):147-51. PubMed ID: 17490542
[TBL] [Abstract][Full Text] [Related]
2. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
[TBL] [Abstract][Full Text] [Related]
3. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
Lee YJ; Benveniste EN
J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739
[TBL] [Abstract][Full Text] [Related]
4. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma).
Kadota Y; Okumura M; Miyoshi S; Kitagawa-Sakakida S; Inoue M; Shiono H; Maeda Y; Kinoshita T; Shirakura R; Matsuda H
Clin Exp Immunol; 2000 Jul; 121(1):59-68. PubMed ID: 10886240
[TBL] [Abstract][Full Text] [Related]
5. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
Rahat MA; Chernichovski I; Lahat N
Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
[TBL] [Abstract][Full Text] [Related]
6. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
7. Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression.
Le Roy E; Mühlethaler-Mottet A; Davrinche C; Mach B; Davignon JL
J Virol; 1999 Aug; 73(8):6582-9. PubMed ID: 10400755
[TBL] [Abstract][Full Text] [Related]
8. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression.
Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ
J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
[TBL] [Abstract][Full Text] [Related]
10. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
12. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
13. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
[TBL] [Abstract][Full Text] [Related]
14. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
Takagi A; Nishiyama C; Kanada S; Niwa Y; Fukuyama K; Ikeda S; Okumura K; Ogawa H
Biochem Biophys Res Commun; 2006 Aug; 347(2):388-93. PubMed ID: 16836979
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.
Nandan D; Reiner NE
J Immunol; 1997 Feb; 158(3):1095-101. PubMed ID: 9013947
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
[TBL] [Abstract][Full Text] [Related]
17. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
Meissner M; Whiteside TL; Kaufmann R; Seliger B
Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
[TBL] [Abstract][Full Text] [Related]
18. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
Murphy SP; Tomasi TB
Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
[TBL] [Abstract][Full Text] [Related]
19. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
Piskurich JF; Wang Y; Linhoff MW; White LC; Ting JP
J Immunol; 1998 Jan; 160(1):233-40. PubMed ID: 9551976
[TBL] [Abstract][Full Text] [Related]
20. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
